Sanofi Will Take 26.4% in German Cheplapharm and Give Him Three Factories
15 Articles
15 Articles
Sanofi and Cheplapharm have been working together since 2014. Now the French are taking part in the German company. Cheplapharm will also be producing medicines for the first time in the future.
"Cheplapharm would resume in Sanofi a selection of 20 mature medicines" including Lovenox, as well as the related sites: that of Csanyikvölgy in Hungary (about 400 employees), of Jurong in Singapore (about 100 employees) and of Ploërmel in France, in Morbihan (about 65 employees), says Sanofi in a press release. "All employees will be resumed with a firm commitment over three years", the number one French pharmaceutical company, which is current…
The Greifswald-based pharmaceutical company Cheplapharm announced a billion-dollar deal on Monday afternoon with the French pharmaceutical company Sanofi, which is one of the world's largest companies with 83,000 employees.
leprogres.fr
The French pharmaceutical giant sells the anticoagulant Lovenox and three production sites of this medicine to Cheplapharm. In return, it enters the capital of the German company.
Sanofi and Cheplapharm have been cooperating since 2014, and in the future the French will hold more than a quarter of the shares of the Greifswald pharmaceutical subgroup. Cheplapharm will receive 20 Sanofi pharmaceutical brands and will take over three factories.
Greifswald/Paris – Greifswald-based pharmaceutical company Cheplapharm plans to increase its annual sales by around one billion euros with a deal with the French pharmaceutical giant Sanofi and to take over three production sites abroad. Cheplapharm is expected to acquire and market 20 medicines from Sanofi. In return, the French...
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
